Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Cancer Research|December 8, 2016
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH BiosynthesisDaniel R Wahl, Joseph Dresser, Kari Wilder-Romans, et al.
NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2025
A Phase 2 Study of Multiparametric Magnetic Resonance Imaging-Guided High-Dose Response-Adaptive Radiation Therapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma: Results From an Interim AnalysisMichelle M Kim, Madhava P Aryal, Krithika Suresh, et al.
Cancer Research|May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade TherapyQiang Zhang, Michael D Green, Xueting Lang, et al.
JCI Insight|February 20, 2024
Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancerQiang Zhang, Long Jiang, Weiwei Wang, et al.
Neuro-Oncology|April 10, 2025
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2021
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed GlioblastomaMichelle M Kim, Yilun Sun, Madhava P Aryal, et al.
Molecular Cancer Therapeutics|July 14, 2026
H3K27M enhances basal ATM signaling but is not required for radiosensitization of diffuse midline glioma via ATM inhibition with AZD1390Erik R Peterson, Leslie A Parsels, Zian Li, et al.
NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Pageof 8